Decreased mechanical efficiency in clinically stable patients with COPD

Thorax

Volumn 52, Issue 11, 1997, Pages 981-986

  Baarends, Erica M ^a,c   Schols, Annemie M W J ^a   Akkermans, Marco A ^b   Wouters, Emiel F M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Asthma Center Hornerheide   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Exercise; Mechanical efficiency

Indexed keywords

ADULT; AIR CONDITIONING; AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; ARTICLE; BLOOD GAS TENSION; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG MECHANICS; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 0030733062     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.11.981     Document Type: Article

References (37)

1. Loke J, Mahler DA, Man P, Wiedemann HP, Matthay RA. Exercise impairment in chronic obstructive pulmonary disease. Clin Chest Med 1984;5:121-42.
2. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152:2021-31.
3. Maltais F, Simard A, Simard C, Jobin J, Descagnés P, LeBlanc P. Oxidative capacity of skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153:288-93.
4. McRussel DM, Walker PM, Leiter LA, Sima AAF, Tanner WK, Mickle DAG, et al. Metabolic and structural changes in skeletal muscle during hypocaloric dieting. Am J Clin Nutr 1984;39:503-13.
5. Schols AMWJ, Soeters PB, Dingemans ANC, Mostert R, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147:1151-6.
6. Schols AMWJ, Mostert R, Soeters PB, Wouters EFM. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 1991;46: 695-9.
7. Cotes JE, Zejda J, King B. Lung function impairment as a guide to exercise limitation in work-related lung disorders. Am Rev Respir Dis 1988;137:1089-93.
8. Baarends EM, Schols AMWJ, Pannemans DLE, Westerterp KR, Wouters EFM. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;155:549-54.
9. Baarends EM, Schols AMWJ, Westerterp KR, Wouters EFM. Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with chronic obstructive pulmonary disease. Thorax 1997;52:780-5.
10. American Thoracic Society. Standards for the diagnoses and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 137:225-8.
11. Quanjer Ph, ed. Standardized lung function testing. Eur Respir J 1993;6(Suppl 16):5-40.
12. Peslin R. Lung mechanics II: resistance measurements. Bull Eur Physiopathol Respir 1983;19(Suppl 5):33-8.
13. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969;99:696-702.
14. Lukaski HC, Bolunchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 1986;60: 1327-32.
15. Schols AMWJ, Dingemans ANC, Soeters PB, Wouters EFM. Within day variation of bioelectrical impedance resistance measurements in patients with chronic obstructive pulmonary disease. Clin Nutr 1990;9:266-71.
16. Schols AMWJ, Schoffelen PF, Ceulemans H, Wouters EFM, Saris WH. Measurement of REE in patients with COPD in a clinical setting. J Parenter Enter Nutr 1992;16:364-8.
17. Noll F. L-(+)-lactate, determination with LDH, GTP and NAD. In: Bergmeyer, ed. Methods of enzymatic analysis. New York: Academic Press, 1974: 1475.
18. Blackie SP, Fairbarn MS, McCelvaney GN, Morrison NJ, Wilco PG, Pardy RL. Prediction of maximal oxygen uptake and power during cycle ergometry in subjects older than 55 years of age. Am Rev Respir Dis 1989;139:1424-9.
19. Carter R, Peavler M, Zinkgraf S, Williams J, Fields S. Predicting maximal exercise ventilation in chronic obstructive pulmonary disease. Chest 1987;92:253-9.
20. Gaesser GA, Brooks GA. Muscular efficiency during steady-rate exercise; effects of speed and work rate. J Appl Physiol 1975;38:1132-9.
21. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109:1-9.
22. Shephard RJ. Efficiency of muscular work. Some clinical implications. Phys Ther 1975;55:476-81.
23. 1 kinetics during exercise in obstructive pulmonary disease. J Appl Physiol 1995;87:2228-34.
24. Levison H, Cherniack RM. Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol 1968;25:21-7.
25. Spiro SG, Hahn HL, Edwards HT, Pride NB. An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. Thorax 1975;30:415-25.
26. Similowski T, Derenne J, Millic Emili J. Respiratory mechanics during acute respiratory failure in chronic obstructive pulmonary disease. In: Derenne J, Whitelaw WA, Similowski T, eds. Acute respiratory failure in chronic obstructive pulmonary disease. Lung Biology in Health and Disease, Vol 92, New York: Marcel Dekker, 1996: 23-46.
27. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:967-75.
28. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic obstructive pulmonary disease. The role of lung hyperinflation. Am Rev Respir Dis 1993;148: 1351-7.
29. deVries HA, Wiswell RA, Romero G, Moritani T, Bulbulian R. Comparison of oxygen kinetics in young and old subjects. Eur J Appl Physiol 1982;49:277-86.
30. Hugli O, Schutz Y, Fitting JW. The daily energy expenditure in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:294-300.
31. Younes M. Interpretation of clinical exercise testing in respiratory disease. Clin Chest Med 1984;5:189-206.
32. Filley GF. Pulmonary ventilation and the oxygen cost of exercise in emphysema. Trans Am Clin Climat Assoc 1958; 70:193-203.
33. Shuey CB, Pierce AK, Johnson RL. An evaluation of exercise tests in chronic obstructive lung disease. J Appl Physiol 1969;27:256-61.
34. Wasserman K, Hansen JE, Shue DY, Whipp BJ. Principles of exercise testing and interpretation. Philadelphia: Lea and Febiger, 1987: 27-46.
35. Baarends EM, Schols AMWJ, Mostert R, Janssen PP, Wouters EFM. A comparison between the 12 minute walking test and incremental cycle ergometry in patients with severe COPD. Am Rev Respir Dis 1993;147:A742.
36. Maltais F, LeBlanc P, Simard C, Jobin J, Bérubé C, Bruneau J, et al. Skeletal muscle adaptation to endurance training in patients wth chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:442-7.
37. Cassaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidose and ventilation as a result of exercise training in patients with chronic obstructive lung disease. Am Rev Respir Dis 1991; 143:9-18.